Dr. Elina Jerschow is a Professor of Medicine (Allergy and Immunology) and an attending physician for pediatric and adult allergy and immunology at Einstein/Montefiore.
After completing her fellowship, Dr. Jerschow joined Merck & Co., Inc. as an associate director in the Department of Clinical Immunology. During the work at Merck, her main research focused on the evaluation of adverse drug reactions in study participants and on developing new therapeutic targets in the area of immunology.
After returning to the Einstein/Montefiore Department of Medicine, Dr. Jerschow established a Center for AERD and Drug Allergy. She is providing continuous care to patients with AERD and allergies to medications. She has also been selected as New York Times Super Doctor and NY Top Doctor for several years.
Dr. Jerschow’s current research goals include the following:
- "Dr. Jerschow’s current research goals are directed at the understanding of the role of nasal polyps and the impact of the immune cell subsets in polyp tissue on AERD severity.
Diagnosis: A Runner Suddenly Developed Asthma. It Was Stranger Than It Seemed New York Times, Dec. 12, 2019
Nasal Polypectomy Is Associated With Reduction In Aspirin Sensitivity In AERD 2019
Delabeling Penicillin Allergies Through Oral Challenges 2019
Explaining Your Running Habit on Vacation. Comments on running during allergy season New York Times, 2018
Asthma Risk Varies Among Hispanic Groups After Relocation to the US 2017
Poor Asthma Sufferers Often Stuck in Homes That Worsen Their Disease 2017
Treatment of Aspirin Exacerbated Respiratory Disease in Minorities 2017
Fatal anaphylaxis in the U.S. 2014
Editor’s pick for featuring in The Editor’s Choice of the J Allergy Clin Immunology. Also featured in the New Research section of the American Academy of Allergy, Asthma and Immunology website
Also cited by major media companies, including The New York Times, US News, Medscape, etc.
Dichlorophenols and allergies 2012
Editor’s pick for press release
Also cited by major media companies, including CNN, Time, Telegraph, Discovery, Voice of America